Home BioNTech

BioNTech

Random

BioNTech

BioNTech Launches Scaled-Down IPO, Raising $150M

BioNTech

Pfizer, BioNTech Plan Clinical Trial for COVID-19 mRNA Vaccine Candidate

BioNTech

Pfizer, BioNTech Begin Phase II/III Trial of COVID-19 Vaccine, Switching Lead Candidate

BioNTech

As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19 Vaccines

Senior male is about to receive Covid-19 coronavirus vaccine

BioNTech

COVID-19: AstraZeneca, U. of Oxford Resume Phase III Trial; Pfizer, BioNTech Eye 14,000 More Participants

BioNTech

Pfizer, BioNTech COVID-19 Vaccine >90% Effective in Early Phase III Data

BioNTech

Pfizer, BioNTech Seek Emergency Use Authorization for COVID-19 Vaccine

BioNTech

Pfizer, BioNTech Gain Temporary U.K. Authorization for COVID-19 Vaccine

BioNTech

FDA Set to Authorize Emergency Use of Pfizer/BioNTech COVID-19 Vaccine

BioNTech

FDA Grants Pfizer, BioNTech Emergency Use Authorization for COVID-19 Vaccine

BioNTech

Pfizer-BioNTech COVID-19 Vaccine Gains Full FDA Approval

BioNTech

FDA Expands Pfizer-BioNTech EUA to Allow Booster Doses for Some Adults

Covid-19 Vaccine Mass Production Manufacture

Coronavirus

FDA Expands EUA for Pfizer/BioNTech COVID-19 Vaccine

BioNTech

FDA OKs Second Booster for Moderna, Pfizer/BioNTech COVID-19 Vaccines

Coronavirus

StockWatch: Novavax Sinks with Revenue Forecast, Vaccine Demand

12 Page 1 of 2